Clinical trial
Study Evaluating the Cost of the Treatments of the Refractory Psoriatic…
NCT00303186 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00303186 |
|---|---|
| Title | Study Evaluating the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional Therapy |
| Official title | An Observational Study to Evaluate the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional Therapy |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Arthritis, Psoriatic, Psoriasis |
| Enrollment | 107 |
| Start date | Feb 1, 2005 |
| Primary completion | Jun 1, 2011 |
| Completion | Jun 1, 2011 |
| First posted | Mar 15, 2006 |
| Last update posted | Jul 30, 2012 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: